Antihypertensive Treatment of Acute Cerebral Hemorrhage-II
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Adnan I Qureshi, MD
University of Minnesota
Study Chair - Adnan I Qureshi, MD
University of Minnesota
Principal Investigator - Yuko Y Palesch, PhD
Medical University of South Carolina
Study Director - Yuko Y Palesch, PhD
Medical University of South Carolina
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
171 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alberta
Edmonton, Alberta, Canada
- Montreal Neurological Institute and Hospital
Montreal, Quebec, Canada
- the Second Hospital of Hebei Medical University
Shijiazhuang, Hebei, China
- the Second Hospital of Shanxi Medical University
Taiyuan, Shanxi, China
- Baotou Central Hospital
Baotou, China
- Beijing Tiantan Hospital
Beijing, China
- Peking University Third Hospital
Beijing, China
- Datong Third People'S Hospital
Datong, China
- the First Hospital of Shanxi Medical University
Taiyuan, China
- the First People'S Hospital of Taizhou
Taizhou, China
- Tianjin Fourth Central Hospital
Tianjin, China
- Renmin Hospital of Wuhan University
Wuhan, China
- Wuhan Brain Hospital
Wuhan, China
- People'S Hopital of Zhengzhou
Zhengzhou, China
- Charité Universtity Medicine Berlin
Berlin, Germany
- University of Bonn
Bonn, Germany
- University Hospital Dresden
Dresden, Germany
- Clinic Frankfurt Hoechst
Frankfurt, Germany
- University Hospital Halle
Halle, Germany
- University Hospital Heidelberg
Heidelberg, Germany
- University Hospital Leipzig
Leipzig, Germany
- University Hospital Mannheim
Mannheim, Germany
- University Hospital Meunster
Münster, Germany
- University of Tubingen
Tübingen, Germany
- Nagoya Medical Center
Nagoya, Aichi-ken, Japan
- Nakamura Memorial Hospital
Sapporo, Hokkaido, Japan
- Saiseikai Yokohamashi Tobu Hospital
Kanagawa, Kanagowa, Japan
- Saiseikai Kumamoto Hospital
Kumamoto, Kumamoto, Japan
- Kyushu Medical Center
Fukuoka, Japan
- Gifu University Hospital
Gifu, Japan
- St. Marianna - Toyoko
Kawasaki, Japan
- St. Marianna University Hospital
Kawasaki, Japan
- Kobe City Medical Center General Hospital
Kobe, Japan
- Kawasaki Medical School
Okayama, Japan
- National Cerebral and Cardiovascular Center
Osaka, Japan
- Kohnan Hospital
Sendai, Japan
- Keio University Hospital
Tokyo, Japan
- Kyorin University
Tokyo, Japan
- Saiseikai Central Hospital - Tokyo
Tokyo, Japan
- Toranomon Hospital
Tokyo, Japan
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 15 May 2011
- Primary completion
- 21 Dec 2015
- Completion
- 8 Mar 2016
- Last update posted
- 25 Apr 2017
- Registered enrollment
- 1,000
- Registry id
- NCT01176565
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.